Quick Answer
PRECISION BIOSCIENCES INC reported Cash And Cash Equivalents At Carrying Value of $110.82 million for the year ending 2025.
- PRECISION BIOSCIENCES INC showed an increase of +29.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from PRECISION BIOSCIENCES INC's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2017: $62.80 million | Q1 2018: $47.75 million | Q2 2018: $125.34 million | Q1 2019: $116.50 million | Q2 2019: $226.10 million | Q3 2019: $206.27 million | Q1 2020: $154.19 million | Q2 2020: $126.89 million | Q3 2020: $104.15 million | Q1 2021: $193.46 million | Q2 2021: $173.94 million | Q3 2021: $160.47 million | Q1 2022: $116.22 million | Q2 2022: $184.14 million | Q3 2022: $212.05 million | Q1 2023: $158.13 million | Q2 2023: $137.79 million | Q3 2023: $122.23 million | Q1 2024: $137.77 million | Q2 2024: $123.57 million | Q3 2024: $98.75 million | Q1 2025: $77.22 million | Q2 2025: $62.24 million | Q3 2025: $44.87 million.
- Over the full 8 years of available data (2018 to 2025), PRECISION BIOSCIENCES INC's Cash And Cash Equivalents At Carrying Value has grown by 7.4%.
- Historical annual values: Fiscal year 2025: $110.82 million | Fiscal year 2024: $85.90 million | Fiscal year 2023: $116.68 million | Fiscal year 2022: $189.58 million | Fiscal year 2021: $143.66 million | Fiscal year 2020: $89.80 million | Fiscal year 2019: $180.89 million | Fiscal year 2018: $103.19 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: